Edaravone shows promise in targeting brain tumor stem cells

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy including surgery, irradiation, and chemotherapy.

Blood Panel Predicts Parkinson’s; Transgender Neurologic Care; Rare COVID Case

A blood panel predicted Parkinson’s disease up to 7 years before symptom onset. (Nature Communications) Homozygosity for R47H in the TREM2 gene substantially raised the

June 26, 2024

Summus Raises $19.5M to Expand Virtual Specialty Care Access

What You Should Know: – Summus, a New York City-based virtual health company focused on specialty care, has raised $19.5M in its latest funding round to

September 14, 2023

State Reports Human Plague Case; Lloyd Austin Admitted Again; Man Dies Mid-Flight

Note that some links may require registration or subscription. Oregon reported its first case of human plague in more than 8 years, which may have

February 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.